N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine
C25H31N5S — CID 152719069
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine
N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine (PubChem CID 152719069) has the molecular formula C25H31N5S and a molecular weight of 433.63 g/mol. Its IUPAC name is N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine.
Molecular Properties
| Compound Name | N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine |
|---|---|
| PubChem CID | 152719069 |
| Molecular Formula | C25H31N5S |
| Molecular Weight | 433.63 g/mol |
| Exact Mass | 433.23 |
| IUPAC Name | N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine |
| SMILES | CN(c1nc2ccc(-c3ccc4nn(C)cc4c3)cc2s1)C1CC(C)(C)NC(C)(C)C1 |
| InChI | InChI=1S/C25H31N5S/c1-24(2)13-19(14-25(3,4)28-24)30(6)23-26-21-10-8-17(12-22(21)31-23)16-7-9-20-18(11-16)15-29(5)27-20/h7-12,15,19,28H,13-14H2,1-6H3 |
| InChIKey | ZVFPXBGDBFBROB-UHFFFAOYSA-N |
| XLogP | 5.60 |
| TPSA | 45.98 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 433.63 |
| LogP ≤ 5 | 5.60 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 152719069 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.